Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

14 results about "Mass spectrometry imaging" patented technology

Mass spectrometry imaging (MSI) is a technique used in mass spectrometry to visualize the spatial distribution of molecules, as biomarkers, metabolites, peptides or proteins by their molecular masses. After collecting a mass spectrum at one spot, the sample is moved to reach another region, and so on, until the entire sample is scanned. By choosing a peak in the resulting spectra that corresponds to the compound of interest, the MS data is used to map its distribution across the sample. This results in pictures of the spatially resolved distribution of a compound pixel by pixel. Each data set contains a veritable gallery of pictures because any peak in each spectrum can be spatially mapped. Despite the fact that MSI has been generally considered a qualitative method, the signal generated by this technique is proportional to the relative abundance of the analyte. Therefore, quantification is possible, when its challenges are overcome. Although widely used traditional methodologies like radiochemistry and immunohistochemistry achieve the same goal as MSI, they are limited in their abilities to analyze multiple samples at once, and can prove to be lacking if researchers do not have prior knowledge of the samples being studied. Most common ionization technologies in the field of MSI are DESI imaging, MALDI imaging and secondary ion mass spectrometry imaging (SIMS imaging).

Method for rapid localization and semi-quantification of novel organic pollutants in zebrafish in vivo by mass spectrometry imaging

PendingCN122385295ACelluloseMass spectrometry imaging
The application relates to a method for rapidly locating and semi-quantitatively analyzing new organic pollutants in zebrafish in vivo by mass spectrometry imaging. The method comprises the following steps: obtaining a whole zebrafish sample after exposure and water flushing; preparing a whole fish frozen section after embedding and freezing by sodium carboxymethyl cellulose (CMC); analyzing the tissue section by using desorption electrospray ionization mass spectrometry imaging (DESI-MSI); simultaneously adding standard samples with a series of concentrations on a blank glass slide, establishing a standard curve based on the average ion intensity; extracting the average ion intensity of a region of interest (ROI) in the tissue section, substituting the average ion intensity into the standard curve to calculate the concentration of the detected substance in the region, and completing semi-quantitative analysis. The application can rapidly and directly locate the distribution of new organic pollutants in different tissues of zebrafish, realize semi-quantitative evaluation of the local concentration of the tissues, and is suitable for ecological toxicology research and risk prediction of new organic pollutants.
Owner:HUBEI PROVINCIAL ACADEMY OF ECO-ENVIRONMENTAL SCIENCES(PROVINCIAL ECOLOGICAL ENVIRONMENT ENGINEERING ASSESSMENT CENTER)

A compound for qualitative or quantitative detection of amine metabolites and its preparation method and use

PendingCN122404216AMetaboliteChemical compound
The application provides a compound for qualitative or quantitative detection of amine metabolites, and a preparation method and use thereof, and belongs to the technical field of biological detection. The compound is shown as formula I. The compound provided by the application can be used as a photochemical derivatization reagent, and the derivatization reagent has good universality, can realize rapid derivatization of various amine metabolites under mild, green and environmentally-friendly conditions. After the amine metabolites are derivatized, the LC-MS analysis method can be used for qualitative and quantitative detection of the amine metabolites, the detection has good specificity, high sensitivity and accuracy, and high repeatability; in addition, mass spectrometry imaging can be used for visual imaging of the amine metabolites. The application provides a new method for detection of amine metabolites, and has good clinical application prospect.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Animal brain metabolite identification method based on mass spectrometry imaging technology and application

The application provides an animal brain metabolite identification method based on mass spectrometry imaging technology and application, and establishes a mouse brain tissue slice endogenous metabolite DESI-MSI analysis method based on mass spectrometry imaging technology, which comprises the following steps: after preparing metabolite control sample imaging samples and brain tissue slice imaging samples, multiple animal brain tissues are attached to the same glass slide, mass spectrometry imaging condition optimization is carried out by using the control sample imaging samples, and mass spectrometry imaging analysis is carried out by using the brain tissue slice imaging samples; the image of the biological sample is divided into multiple structure regions in combination with tissue morphological characteristics; for the structure regions, multivariate statistical analysis is carried out to obtain different metabolites in different structure regions; metabolite identification is carried out based on parent ions and characteristic daughter ion profiles; and the method is used for disease mechanism research and drug intervention effect evaluation on diseases.
Owner:THE NAVAL MEDICAL UNIV OF PLA

A method, apparatus, storage medium, and electronic device for in-situ batch acquisition of MS2 data.

ActiveCN121049373BReduce the risk of puncturequality improvementMaterial analysis by electric/magnetic meansResolution (mass spectrometry)Data acquisition
This application relates to a method, apparatus, storage medium, and electronic device for in-situ batch acquisition of MS2 data, belonging to the field of mass spectrometry imaging technology. The method includes: acquiring MS1 data of a sample to be acquired; determining at least one specific mass-to-charge ratio based on the MS1 data; reducing the initial resolution of the sample to be acquired to a target resolution to obtain a target acquisition sample; determining target acquisition pixels for each specific mass-to-charge ratio precursor ion from all pixels in the target acquisition sample, wherein the target acquisition pixel is the pixel with the highest mass spectrometric signal intensity for the corresponding specific mass-to-charge ratio among all pixels; acquiring MS2 data for the corresponding precursor ions with the specific mass-to-charge ratio based on each target acquisition pixel to obtain corresponding initial MS2 data; and performing quality screening on each initial MS2 data to obtain screened target MS2 data. This application improves the quality of the acquired MS2 data.
Owner:WUHAN METWARE BIOTECHNOLOGY CO LTD

A ct three-dimensional reconstruction coordinate-assisted mass spectrometry imaging method and system

ActiveCN121703232BMaterial analysis by electric/magnetic meansResolution (mass spectrometry)High spatial resolution
The application relates to the field of electronic information technology and discloses a CT three-dimensional reconstruction coordinate-assisted mass spectrum imaging method and system. The method comprises the following steps: acquiring scanning data of a sample to be measured and reconstructing a three-dimensional digital model; based on the three-dimensional digital model, planning sampling points on the surface of the sample, a laser desorption path and a sample posture angle at each sampling point; controlling the sample to move along the laser desorption path, so that when each sampling point on the sample reaches the focal point of a laser beam of an atmospheric pressure laser desorption / secondary photoionization device, the sample surface at the sampling point is desorbed at the planned sample posture angle, and mass spectrum data is collected through a mass spectrometer; and the collected mass spectrum data is associated with the three-dimensional space coordinates of the corresponding sampling points, and a three-dimensional distribution image of molecules on the surface of the sample to be measured is reconstructed. The application can realize high-spatial-resolution and high-sensitivity mass spectrum imaging on a sample which is too fragile to be sliced and an irregular sample surface.
Owner:UNIV OF SCI & TECH OF CHINA

An amino-reactive matrix, its method of preparation and use in mass spectrometry imaging

The application relates to an amino reactive matrix, a preparation method thereof and application thereof in mass spectrometry imaging, and belongs to the field of organic synthesis and spatial metabolomics research. The amino reactive matrix is applied to the field of spatial omics research of metabolic small molecules of biological tissue samples, and provides important technical support for realizing spatial distribution information of amino small molecules (such as neurotransmitters, amino acids and the like) in disease model tissue samples.
Owner:DALIAN INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES

Ion source and mass spectrometry imaging system for high resolution mass spectrometry imaging

PendingCN122459910AResolution (mass spectrometry)Electro spray
The application relates to an ion source (00) for high-resolution mass spectrum imaging and a mass spectrum imaging system, the ion source (00) comprising a first carrier table (001), a second carrier table (002), an ionization electrode (003), a high-voltage power supply (004), a scanning probe (005), a micro flow pump (006) and a control device (007); the first carrier table (001) is provided with a first holder (011) for clamping a slide (110), and the tissue slice sample (220) on the front surface of the slide (110) clamped by the first holder (011) faces the sample inlet (330) of a mass spectrometer (33); the second carrier table (002) is provided with a second holder (012) for clamping the scanning probe (005), and the scanning probe (005) is connected with the micro flow pump (006) through a conduit (008); the ionization electrode (003) faces the sample inlet (330) of the mass spectrometer (33) and is located on the back surface of the slide (110) clamped by the first holder (011), and the ionization electrode (003) is electrically connected with the high-voltage power supply (004); and the control device (007) is electrically connected with the first carrier table (001), the second carrier table (002), the high-voltage power supply (004) and the micro flow pump (006) respectively. Thus, a picoliter droplet analytical electrospray ion source (00) with higher sensitivity and spatial resolution in mass spectrum imaging technology is realized.
Owner:TSINGHUA UNIVERSITY

A spatiotemporal decoupling mass spectrometry imaging method based on droplet storage

PendingCN122361579AResolution (mass spectrometry)Mass Spectrometry-Mass Spectrometry
This invention discloses a spatiotemporally decoupled mass spectrometry imaging method based on droplet storage, comprising the following steps: (1) micro-area sampling; (2) liquid bridge capture; (3) droplet encapsulation; (4) generation of droplet array; and (5) droplet release and mass spectrometry analysis. This invention completely decouples imaging sampling from subsequent analysis in space and time. Through steps such as micro-area sampling and droplet encapsulation, sample information is stored in the form of droplets, and subsequent analysis is performed. This achieves independent optimization of the three major processes of sampling, storage, and analysis, which not only greatly expands the range of analyzable samples but also eliminates the negative impact of preprocessing on imaging resolution from the root, meeting the requirements of different application scenarios for analytical efficiency and accuracy.
Owner:ZHEJIANG UNIV

Imaging method, device, computer device and storage medium of brain tissue

ActiveCN119023778BImage resolutionRadiology
The application belongs to the field of mass spectrometry imaging, and provides a brain tissue imaging method and related equipment, which can improve the spatial resolution of the mass spectrum image of a brain tissue slice. The method comprises the following steps: determining the position parameter of a fine probe corresponding to a target brain tissue slice; controlling a target spray solvent to bombard the surface of the target brain tissue slice at a predetermined flow rate in the fine probe, so that the target brain tissue slice is desorbed and ionized; controlling the fine probe to scan the target brain tissue slice after desorption and ionization at a preset step length according to the position parameter, so as to obtain mass spectrum raw data corresponding to the target brain tissue slice; and determining a mass spectrum image corresponding to the target brain tissue slice according to the mass spectrum raw data corresponding to the target brain tissue slice.
Owner:INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI

Disease treatment mechanism analysis method, system and application based on combination of single cell sequencing, spatial transcriptome and mass spectrometry imaging

PendingCN122157781AMicrobiological testing/measurementPreparing sample for investigationTissue stainingMass spectrometry imaging
The application provides a disease treatment mechanism analysis method, system and application based on single-cell sequencing, spatial transcriptome and mass spectrometry imaging, and specifically belongs to the technical field of multi-omics analysis.The disease treatment mechanism analysis method comprises the following steps: preparing a tissue section;respectively performing tissue staining, single-cell sequencing, Spatial-seq 2.0 spatial transcriptome sequencing and mass spectrometry imaging on the tissue section; and performing single-cell spatial multi-omics affine registration and data joint analysis.The disease treatment mechanism analysis method fuses the data of multiple omics, has high spatial resolution, can realize cell subtype positioning, can comprehensively analyze the multidimensional mechanism of drug treatment of complex diseases from gene expression to metabolite, and breaks through the spatial and data integration limitations of traditional technologies.
Owner:ZHEJIANG UNIV

A label-free device and method for in situ detection of single-cell membranes

This invention discloses a label-free, in-situ detection device and method for single-cell membranes, belonging to the field of mass spectrometry imaging technology. The device sequentially comprises a VUV laser generator, a spectrometer, an ionization chamber, a Time-of-Flight (TOF) mass analyzer, and a data acquisition processor. The spectrometer includes a spectroscopic system. This invention utilizes a lens focusing method, adjusting the distance between plano-convex mirrors in the spectroscopic system to split and focus the VUV laser, resulting in a minimal focused spot. The optimal lateral and longitudinal resolution (12 nm) of the device was determined by characterizing the spot size. Using this device to detect HeLa cell membranes, it was confirmed that it can accurately peel off real cell membranes, effectively improving the device's resolution, especially the longitudinal resolution, providing more accurate reference information for fields such as cancer research, cell communication, drug screening, and disease diagnosis.
Owner:NANJING UNIV

A multi-modal molecular imaging method and device based on dynamic iterative calibration of DESI mass spectrometry

PendingCN122306928AMolecular imagingMass Spectrometry-Mass Spectrometry
This application provides a multimodal molecular imaging method and apparatus based on DESI mass spectrometry dynamic iterative calibration, which can balance high-throughput data acquisition and high-precision molecular imaging. The method includes: acquiring optical imaging data of a sample to be tested; selecting multiple calibration points from the sample to be tested based on the optical imaging data to obtain a sparse calibration point set; acquiring mass spectrometry imaging data of each calibration point in the sparse calibration point set; establishing a mapping model between the mass spectrometry imaging data and the corresponding optical imaging data using the mass spectrometry imaging data of each calibration point in the sparse calibration point set as a reference true value; and calibrating the optical imaging data of the sample to be tested based on the mapping model to generate a molecular image of the sample to be tested.
Owner:NATIONAL INSTITUTE OF METROLOGY CHINA +1